Financials Xilong Scientific Co., Ltd.

Equities

002584

CNE1000013M8

Commodity Chemicals

End-of-day quote Shenzhen S.E. 06:00:00 2024-04-25 pm EDT 5-day change 1st Jan Change
6.77 CNY +1.96% Intraday chart for Xilong Scientific Co., Ltd. +1.80% -30.85%

Valuation

Fiscal Period: December 2017 2018 2019 2020 2021 2022
Capitalization 1 10,604 3,529 2,973 3,400 6,203 4,056
Enterprise Value (EV) 1 10,377 3,869 3,111 3,417 5,996 4,183
P/E ratio 121 x 50.3 x 72.6 x 58.1 x 30.3 x 46.2 x
Yield - - - - - -
Capitalization / Revenue 3.21 x 1.02 x 0.89 x 0.54 x 0.91 x 0.66 x
EV / Revenue 3.14 x 1.12 x 0.93 x 0.55 x 0.88 x 0.68 x
EV / EBITDA 82.9 x 30.8 x 20.7 x 33.3 x 35.1 x 35.6 x
EV / FCF -307 x -14.2 x 18.5 x -17.4 x 73.7 x -13.2 x
FCF Yield -0.33% -7.02% 5.41% -5.75% 1.36% -7.6%
Price to Book 6.25 x 2 x 1.53 x 1.69 x 2.77 x 1.76 x
Nbr of stocks (in thousands) 585,216 585,216 585,216 585,216 585,216 585,216
Reference price 2 18.12 6.030 5.080 5.810 10.60 6.930
Announcement Date 3/22/18 4/28/19 6/14/20 4/28/21 4/21/22 4/28/23
1CNY in Million2CNY
Estimates

Income Statement Evolution (Annual data)

Fiscal Period: December 2017 2018 2019 2020 2021 2022
Net sales 1 3,305 3,445 3,338 6,243 6,838 6,165
EBITDA 1 125.2 125.6 150.5 102.6 170.7 117.5
EBIT 1 91.85 91.32 116.3 75.04 142.9 83.18
Operating Margin 2.78% 2.65% 3.49% 1.2% 2.09% 1.35%
Earnings before Tax (EBT) 1 97.34 71.31 46.2 81.25 227.3 91.11
Net income 1 89.85 73 38.53 56.87 203.9 88.05
Net margin 2.72% 2.12% 1.15% 0.91% 2.98% 1.43%
EPS 2 0.1500 0.1200 0.0700 0.1000 0.3500 0.1500
Free Cash Flow 1 -33.75 -271.8 168.5 -196.4 81.32 -318
FCF margin -1.02% -7.89% 5.05% -3.15% 1.19% -5.16%
FCF Conversion (EBITDA) - - 111.94% - 47.65% -
FCF Conversion (Net income) - - 437.24% - 39.89% -
Dividend per Share - - - - - -
Announcement Date 3/22/18 4/28/19 6/14/20 4/28/21 4/21/22 4/28/23
1CNY in Million2CNY
Estimates

Balance Sheet Analysis

Fiscal Period: December 2017 2018 2019 2020 2021 2022
Net Debt 1 - 340 138 17.1 - 127
Net Cash position 1 227 - - - 207 -
Leverage (Debt/EBITDA) - 2.711 x 0.9184 x 0.1667 x - 1.081 x
Free Cash Flow 1 -33.8 -272 168 -196 81.3 -318
ROE (net income / shareholders' equity) 4.67% 3.71% 1.82% 3.12% 9.88% 3.19%
ROA (Net income/ Total Assets) 2.36% 1.9% 1.88% 1.08% 1.95% 1.06%
Assets 1 3,800 3,832 2,051 5,247 10,440 8,289
Book Value Per Share 2 2.900 3.010 3.320 3.450 3.830 3.950
Cash Flow per Share 2 0.7000 1.390 2.080 1.240 1.320 1.180
Capex 1 36.3 16 9.81 38.2 56.7 324
Capex / Sales 1.1% 0.46% 0.29% 0.61% 0.83% 5.25%
Announcement Date 3/22/18 4/28/19 6/14/20 4/28/21 4/21/22 4/28/23
1CNY in Million2CNY
Estimates

EPS & Dividend

Year-on-year evolution of the PER

Change in Enterprise Value/EBITDA

Annual profits - Rate of surprise

  1. Stock Market
  2. Equities
  3. 002584 Stock
  4. Financials Xilong Scientific Co., Ltd.